BriefingIndustry newsIndustry briefingCovid-19 briefingNEWSFDA approves Gilead’s Veklury for Covid-19 in paediatric patientsBRIEFINGGlyscend concludes Phase I trial of oral type 2 diabetes therapyIn the trial, GLY-200 was found to be well-tolerated across all tested dose levels without any safety signals detected.covid-19Covid-19 vaccines and strong capital markets still drive Pharma growthAccording to an ongoing GlobalData poll, the biggest impact of the Covid-19 pandemic has been in supply chain.Industry newsIndustry briefingCovid-19 briefing02/23/2024 23:27:09
covid-19
Covid-19 vaccines and strong capital markets still drive Pharma growth
According to an ongoing GlobalData poll, the biggest impact of the Covid-19 pandemic has been in supply chain.